The Food and Drug Administration licensed the first freeze-dried plasma product ever authorized in the United States on July 30, a landmark advance in trauma medicine that extends plasma’s shelf life from days to years without refrigeration.
The approval addresses a longstanding gap in American emergency medical capability. Allied military forces have used comparable freeze-dried plasma products for years, while U.S. service members and civilian trauma patients lacked access to an FDA-licensed domestic option.
Conventional fresh frozen plasma requires continuous cold-chain storage — an unbroken series of refrigerated transport and storage conditions — that severely limits its availability in battlefield settings, mass casualty events, rural trauma care, and disaster response. Freeze-dried plasma can be stored at room temperature and reconstituted rapidly with sterile water when needed.
The approval comes as U.S. military forces are engaged in active combat operations against Iranian targets, making battlefield trauma care an immediate operational concern. Military medical officials have long advocated for a licensed freeze-dried plasma product to improve survival rates for wounded service members in austere environments.
Beyond military applications, the product could transform civilian trauma care in the United States. Rural hospitals and emergency medical services that cannot maintain refrigerated blood product inventories would gain access to a critical lifesaving treatment they currently lack.
The FDA said it evaluated the product through its biologics licensing pathway, reviewing clinical data on safety, purity, and potency. The agency described the authorization as a significant milestone in expanding access to blood products in settings where conventional storage is impractical.
Mass casualty incidents — including natural disasters, industrial accidents, and active shooter events — present scenarios where demand for plasma can surge far beyond the capacity of local blood banks, making shelf-stable alternatives a public health priority.